Concepedia

David Vanda

DV

5

Publications

121

Citations

5

H-Index

2015

Active since

Affiliations

Palacký University Olomouc(Current)

Institute of Molecular and Translational Medicine

Jagiellonian University

Inserm

Université de Montpellier

David Vanda is an author at Palacký University Olomouc specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2015–2021

5

Publications

5

Novel non-sulfonamide 5-HT 6 receptor partial inverse agonist in a group of imidazo[4,5- b ]pyridines with cognition enhancing properties

David Vanda, Miroslav Soural, Vittorio Canale et al. · European Journal of Medicinal Chemistry · 2017 · 46 citations · Full text

, , +6

New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases

Veronika Ručilová, Artur Świerczek, David Vanda et al. · European Journal of Medicinal Chemistry · 2020 · 25 citations · Full text

, , +11

Imidazopyridine-Based 5-HT<sub>6</sub> Receptor Neutral Antagonists: Impact of <i>N</i><sup>1</sup>-Benzyl and <i>N</i><sup>1</sup>-Phenylsulfonyl Fragments on Different Receptor Conformational States

David Vanda, Vittorio Canale, Séverine Chaumont‐Dubel et al. · Journal of Medicinal Chemistry · 2021 · 21 citations · Full text

Synthesis of Novel N<sup>9</sup>-Substituted Purine Derivatives from Polymer Supported α-Amino Acids

David Vanda, Radek Jorda, Barbora Lemrová et al. · ACS Combinatorial Science · 2015 · 15 citations

, , +16

1,4,6-Trisubstituted imidazo[4,5-c]pyridines as inhibitors of Bruton’s tyrosine kinase

Soňa Krajčovičová, Radek Jorda, David Vanda et al. · European Journal of Medicinal Chemistry · 2020 · 14 citations · Full text

, , +5

Rows per page

1–5 of 5